ImmuCell
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $7,751 | $6,011 | $5,472 | $7,257 |
Gross Profit | 2,832 | 1,583 | 1,230 | 2,295 |
EBITDA | 1,297 | -574,894 | -716 | 376 |
EBIT | 622 | -575,569 | -1,387 | -290 |
Net Income | 515 | -701 | -1,531 | -437 |
Net Change In Cash | 7,751 | 6,011 | 5,472 | 7,257 |
Free Cash Flow | -727 | 471 | 348 | |
Cash | 3,808 | 1,324 | 960 | |
Basic Shares | 8,935 | 8,164 | 7,810 | 7,750 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $26,493 | $17,471 | $18,568 | $19,243 |
Gross Profit | 7,941 | 4,396 | 7,649 | 8,656 |
EBITDA | 1,044 | -2,504 | 188 | 2,717 |
EBIT | -1,640 | -5,221 | -2,299 | 245 |
Net Income | -2,157 | -5,774 | -2,494 | -78 |
Net Change In Cash | 26,493 | 17,471 | 18,568 | 19,243 |
Free Cash Flow | -6,566 | -5,519 | -1,654 | |
Cash | 978 | 5,792 | 10,185 | |
Basic Shares | 8,167 | 7,747 | 7,745 | 7,592 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.05 |
2024-09-30 | -$0.08 |
2024-06-30 | -$0.19 |
2024-03-31 | -$0.05 |
